Skip to Content
MilliporeSigma

Deliver Global Solutions Locally

New South Korea Bioprocessing Production Center

Increasing Supply Robustness and Resilience

Timely, reliable supply of bioprocessing materials used for the development and commercial manufacturing of biotherapeutics, and vaccines is a critical requirement for drug manufacturers worldwide.

Our new 44,500 m² production center in Daejeon, South Korea, set to open in 2026, marks a significant expansion of our manufacturing capacities and capabilities for essential bioprocessing products including:

The production facility will address the growing Asia-Pacific demand for bioprocessing materials to manufacture monoclonal antibodies (mAbs), recombinant proteins, antibody-drug conjugates (ADCs), and other novel modalities. Regionalization and proximity to this plant will benefit local biomanufacturers by:

  • Reducing lead times thanks to additional manufacturing capacity and shorter shipment distances
  • Improving sourcing and supply resilience with in-region for-region production
  • Improving sustainability through streamlined logistics with short transportation distances

The site encompasses modern, advanced, and segregated manufacturing suites, and is home to distribution, automated storage & retrieval, administration as well as wastewater treatment facilities.

Get in Touch with Us

EXPLORE OUR PRODUCTS & SERVICES MANUFACTURED IN THIS NEW FACILITY

Slide 1 of 5
A
Dry Powder & Liquid Cell Culture Media

Choose high quality media fit for your application: from standard to custom formulation, from liquid to dry powder helping you to optimize cell growth.

A
CIP Solutions

To ensure the highest standards of purity and quality for your processes, discover our GMP-grade (IPEC/EXCiPACT) solutions for CIP and buffer preparation.

A
Liquid Ready to Use Downstream Buffers

Discover our extensive portfolio of buffers designed to accommodate different stages of drug manufacturing from early-stage to high-risk applications.

A
Sterile Sampling

Reduce contamination risks and enable accurate, representative sample collection for reliable process control at any step of your process.

A
imMEDIAte Advantage® Services

Get fast access to pre-GMP small-scale custom media, feeds, supplements, and buffers to accelerate your drug development.

Ensuring One Global Quality System

The Daejeon site will adhere to the highest standards of quality compliance, fully aligning with our stringent global quality standards. This state-of-the-art facility is designed to ensure consistent product performance and reliability, reflecting our commitment to excellence across our global manufacturing network.

Embedding Sustainability

We are applying “green building” standards and aim to achieve a net-zero design for the facility. We will use a variety of resource-efficient equipment including solar panels for electricity, a heat-pump system for heating, energy-efficient equipment and automation, and water collection systems to reduce water use. 

Facts & Figures

 

A yellow graphic of a dollar sign surrounded by a circular arrow. A yellow graphic of mountains surrounded by a circle. A yellow graphic of a building. A white graphic of an office surrounded by a yellow circle. A white graphic of a hard hat surrounded by a yellow circle. A white graphic of a building surrounded by a yellow circle.
300+ M€ Investment 43,000 m2 Land
 		 44,500 m2 Facility
 		 300+ New Jobs
 		 Groundbreaking:
May 2024		 Grand Opening:
Expected Q4 2026

Related Resources

Related Product Categories
Bioprocessing Cell Culture Media & Feeds
Our off-the-shelf and customizable bioprocessing cell culture media (CCM) products enhance productivity in upstream mAb, vaccine, gene/cell therapy processes.
Sterile and Aseptic Sampling Solutions
Flexible. Safe. Contamination free. Closed system ensures aseptic processing conditions. With configurable holders and single-use sampling assemblies, NovaSeptum® GO sterile sampling system provides representative samples for QC labs testing for bioburden, endotoxin, process sterility, and monitoring pH and osmolality.
Bioprocessing Cell Culture
Browse our cell culture products for manufacturing, including our cell culture media, cell culture ingredients and supplements, bioreactors, and clarification filters.
Bioprocessing Liquid Cell Culture Media & Buffers
We offer the industry’s highest quality sterile liquid capabilities, supplying ready-to-use cell culture media, buffers, CIP and SIP products from GMP facilities worldwide to optimize your biopharma production.
Cell Culture Media & Buffers
Standard, complex, and specialty cell culture media for a variety of cell lines and applications. We also offer starting buffers and supplements used in custom media development.
Related Applications
Monoclonal Antibodies (mAbs)
Explore cutting-edge monoclonal antibodies (mAbs) technologies, from antibody drug discovery to antibody engineering and therapeutic antibodies commercialization. Whether in early research or seeking a CDMO partner, benefit from our expertise, products, and services in antibody drug innovation.
mRNA Therapeutics
Our comprehensive portfolio of products and services provides everything you need for mRNA synthesis, purification, and formulation for development and manufacturing.
Cell Culture for Manufacturing
Biologics manufacture: Cell culture's role in therapeutic protein, antibody, cell therapy, and vaccine production.
Biopharma 4.0: Digital Transformation
Bioprocessing 4.0 integrates advanced technologies for future biomanufacturing facilities.
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Gene Therapy Manufacturing
Gene therapy innovation requires integrated manufacturing, testing, safety, and compliance expertise from experienced partners.
Cell Therapy Manufacturing
Introducing a new cell therapy demands optimal performance in upstream and downstream processing, process development, testing, and manufacturing. World-class products and partners are critical to success, speeding advancement of therapeutics that are effective, safe, and affordable.
Antibody Drug Conjugate Manufacturing
Antibody drug conjugates (ADCs) use mAbs to deliver highly potent active pharmaceutical ingredients to target cells. Explore capabilities and expertise needed for successful ADC development and manufacturing.
Related Services
Custom Media Development Services
Our Media Development Services will identify a custom media solution that meets your objectives for cell growth, titer, protein quality profile, as well as media, feed, and perfusion requirements.
Custom Solutions for Cell Culture
Leverage our global manufacturing network, quality management expertise, and comprehensive services for cell culture solutions tailored exactly to your needs.
Cell Culture Media Stability and Testing Services
Our cell culture media stability and testing services can provide an assigned expiration date for custom products, or test for nutritional component data to optimize your bioprocess.
Critical Raw Materials
Our customized portfolio of high-quality critical raw materials for API synthesis supplies the solvents, reagents, documentation, and expertise you need to meet stringent regulatory requirements and mitigate risk in all aspects of small molecule drug development and manufacturing.
Emprove® Program – Two Decades of Easing Risk Management
Emprove® Program streamlines compliance with technical, regulatory, and supply information in Emprove® Dossiers, supporting risk assessment.
Single-Use and Filter Validation Services
BioReliance® Validation Services streamline validation processes for filters, assemblies, and single-use systems in drug manufacturing.

Get in Touch with Us

Fields indicated by an * are required.

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?